Trends in the burden of HPV-associated cancers in Mexico: An analysis from 2011 to 2019 [0.03%]
2011年至2019年墨西哥HPV相关癌症负担趋势分析
Juan Carlos Orengo,Ana Luiza Bierrenbach,Carlos Eduardo Aranda Flores et al.
Juan Carlos Orengo et al.
Human papillomavirus (HPV) is a major public health concern, responsible for multiple types of cancer. This study aimed to provide an overview of the burden and temporal trends of HPV-associated cancers in Mexico using national hospital dis...
When Immunity Backfires: Pembrolizumab-Induced Bilateral Pneumothorax in a Patient with Metastatic HPV-Associated Oropharyngeal Carcinoma [0.03%]
免疫功能过度所致的派姆单抗致双侧气胸：一例转移性HPV相关型口咽癌患者的病例报告
Shahzeb Saeed,Daniyal Khan,Saman Hamid et al.
Shahzeb Saeed et al.
Background: Immune checkpoint inhibitors (ICIs) are standard therapy for recurrent or metastatic head and neck squamous cell carcinoma, but unleashing antitumour immunity can trigger immune-related adverse events (irAEs)....
Salivary and Serum Liquid Biopsy Biomarkers for HPV-Associated Oral and Oropharyngeal Cancer: A Narrative Review [0.03%]
唾液和血清液体活检生物标志物在HPV相关口腔及口咽癌中的应用：综述性文章
Saman Warnakulasuriya,Shankargouda Patil
Saman Warnakulasuriya
Background: Human papillomavirus (HPV)-associated oral and oropharyngeal squamous cell carcinomas have risen dramatically in incidence over recent decades. Yet, unlike cervical neoplasia, there is no established screening paradigm for HPV-d...
Liquid biopsy for very early detection of HPV-associated oropharyngeal cancer [0.03%]
用于人乳头瘤病毒相关性口咽癌的液体活检早期诊断研究
David M Routman,Axel M Hidalgo,Aadel A Chaudhuri
David M Routman
Neoadjuvant chemoimmunotherapy in HPV-associated vulvar and vaginal squamous cell carcinoma with PD-L1 CPS < 1:Dual pCR evidence [0.03%]
HPV相关型外阴和阴道鳞癌新辅助化疗免疫治疗PD-L1 CPS
Enyu Tang,Jia Zeng,Yangchun Sun
Enyu Tang
Background: While surgery and radiotherapy remain primary treatments for HPV-associated vulvar/vaginal squamous cell carcinoma (SCC), the significant complications and impaired quality of life underscore the need for alte...
RUVBL1: A promising prognostic indicator for HPV-associated oral squamous cell carcinoma [0.03%]
RUVBL1：HPV相关口腔鳞状细胞癌预后标志物的希望携带者
Shyamaladevi Babu,Madhan Krishnan
Shyamaladevi Babu
Advances in Prevention, Screening, and Early Detection of HPV-Associated Head and Neck Cancers [0.03%]
HPV相关头颈癌的预防、筛查和早期检测进展
Evangelos Zazas,Panagiota Economopoulou,Ioannis Kotsantis et al.
Evangelos Zazas et al.
HPV-related head and neck cancers are increasing globally and although they constitute a major public health problem, there are currently no validated screening or early detection methods in widespread clinical use. This review discusses ad...
Exosomes in HPV-Associated Cancers: From Biomarkers to Engineered Therapeutics [0.03%]
人乳头瘤病毒相关癌症的外泌体：从生物标志物到工程治疗学
Muharrem Okan Cakir,Melis Selek,Betul Yilmaz et al.
Muharrem Okan Cakir et al.
Background/objectives: Human papillomavirus (HPV) is the main causative agent of cervical cancer and contributes to a significant proportion of other anogenital and oropharyngeal malignancies. The need for better biomarke...
Apparent Diffusion Coefficient MRI as a Predictive Biomarker for Hypoxia, Treatment De-escalation, and Recurrence in HPV-Associated Oropharyngeal Cancer [0.03%]
人乳头瘤病毒相关型口咽癌表观扩散系数MRI作为低氧、降级治疗和复发的预测生物标志物
James E Han,Bill H Diplas,Ramesh Paudyal et al.
James E Han et al.
Purpose: To evaluate whether quantitative diffusion-weighted magnetic resonance imaging (DW-MRI) derived apparent diffusion coefficient (ADC) parametric values of nodal disease can identify nodal recurrence (NR) risk and ...
Refining prognosis and Personalizing Therapy: A Step Forward with Machine learning in HPV-Associated head and neck cancer [0.03%]
利用机器学习精确诊断和个性化治疗HPV相关头颈癌
Rupsa Das,Satya Ranjan Misra,Satya Sundar Gajendra Mohapatra
Rupsa Das
耗时 0.09146 秒，为您在
48948952
条记录里面共找到 744 篇文章 [XML]